Navigation Links
Osteocalcin ELISA Kit from Invitrogen

ProductsOsteocalcin ELISA Kit from Invitrogen
Company Invitrogen
Item Osteocalcin ELISA Kit
Price 
Description The Gla-type Osteocalcin EIA Kit is an in vitro enzyme immunoassay (EIA) kit for quantitative determination of human Gla-OC in serum, cultured cell extracts, cell culture supernatants, and other biological fluids. This kit is for research use only. It is not for use in diagnostic or therapeutic procedures.
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Anti-Osteocalcin (1-22), 1-22 h Osteocalcin Polyclonal Antibody, Unconjugated from CHEMICON
2. Free Activin A ELISA Kit from Diagnostic Systems Laboratories, Inc.
3. Free Activin AB ELISA Kit from Diagnostic Systems Laboratories, Inc.
4. Free Activin B ELISA Kit from Diagnostic Systems Laboratories, Inc.
5. HIV-1 p24 ELISA Kit, Alliance (480 Tests) from PerkinElmer
6. Porcine Leptin ELISA Kit from Diagnostic Systems Laboratories, Inc.
7. Equine TNF alpha ELISA development Kit, Screening Set from Endogen
8. Staccato Sciclone ELISA Station from Caliper Life Sciences
9. Telomerase ELISA Assay Kit, TRAPEZE from CHEMICON
10. Nuclear Matrix Protein ELISA Kit from Calbiochem
11. Rat TRACP 5b ELISA Kit, TRAPTM from IDS Ltd
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
...
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Request Info...
Biology Products:
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/6/2015)... Israel , May 6, 2015 LifeBEAM, ... most established helmet producer, announced today that they will ... Helmet, the world,s first bio-sensing cycling helmet and the ... released in two new colors in order to give ... the product. In addition, LifeBEAM and Lazer announced their ...
(Date:4/27/2015)... FORT LAUDERDALE, Fla. , Apr. 27, 2015 /PRNewswire/ ... provider of access control and security systems is pleased ... joined the company as a consultant and member of ... Bedore is widely known as a thought leader ... Socrates Distance Learning Technology Group, and has published studies ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... to be a godsend for many of the two ... its downside. People on the drug may develop hypothyroidism, ... gain weight. , However, better treatments for bipolar disorder ... by which lithium damps the highs and lows of ...
... they see colors when viewing letters and numbers really ... of the University of California San Diego, have found. ... brains reveals that they show activation of color-perception areas. ... the hypothesis that the condition is due to cross-activation ...
... have found a way of stimulating the immune ... cause the devastating plaques,that are characteristic of Alzheimer's ... using a,protein-based vaccine to slow the progression of ... have created a gene-based,vaccine aimed at stimulating the ...
Cached Biology News:Beyond lithium for bipolar disorder 2New insight into people who 'see' colors in letters and numbers 2Gene vaccine for Alzheimer's disease shows promising results 2
(Date:5/21/2015)... , May 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ... sciences company that develops and commercializes proprietary technologies and ... and operational results for the second fiscal quarter ended ... the Company continued to advance business with our existing ... Morris , President and CEO of SQI. "The delivery ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Seventh Wave ... safety and efficacy of pharmaceutical products and medical devices, ... Heights, MO 63043, a 50,000 sq. ft. building more ... to enable strategic growth. Facility renovations will begin immediately ... new space will occur in September. , “We ...
(Date:5/21/2015)... May 21, 2015 Specialty Pharmacy ... and been admitted to BPA Worldwide as a ... will track audience data for Specialty Pharmacy Times ... , “By becoming a member of BPA Worldwide, ... providing our clients with the most reliable, unequaled ...
(Date:5/21/2015)... NEW YORK , May 21, 2015 /PRNewswire/ ... Prader-Willi Research (FPWR), a nonprofit organization dedicated to ... of Prader-Willi syndrome (PWS), announced today that FPWR ... Leon and Irina Shaulov contributed $1 ... and clinical initiatives.  ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Specialty Pharmacy Times Joins BPA Worldwide 2The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2